Find clinical trials for Lymphoma in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Rochester, MN, USA:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Rochester, Minnesota, United States and 89 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Rochester, Minnesota, United States and 126 other locations
(R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. However, single drug therapies have limitations, therefore, the current...
Phase 2
Rochester, Minnesota, United States and 7 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Rochester, Minnesota, United States and 59 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Rochester, Minnesota, United States and 215 other locations
The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during...
Phase 1, Phase 2
Rochester, Minnesota, United States and 9 other locations
study is to find out whether the combination of glofitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma...
Phase 1
Rochester, Minnesota, United States and 9 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Rochester, Minnesota, United States and 64 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Rochester, Minnesota, United States and 29 other locations
or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...
Phase 1
Rochester, Minnesota, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal